{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wang R"],"funding":["This study was supported by the Senior Medical Talents Program of Chongqing for Young and Middle-aged","the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","National Natural Science Foundation of China","the program of Science and Technology Bureau of Yuzhong District, Chongqing"],"pagination":["110"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10938667"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["22(1)"],"pubmed_abstract":["<h4>Background</h4>Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substantially challenging. Abnormal tumor vessels play a crucial role in TNBC progression and treatment. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis, while effective NO delivery can normalize the tumor vasculature. Accordingly, we have proposed here a tumor vascular microenvironment remodeling strategy based on NO-induced vessel normalization and extracellular matrix collagen degradation with multimodality imaging-guided nanoparticles against TNBC called DNMF/PLGA.<h4>Results</h4>Nanoparticles were synthesized using a chemotherapeutic agent doxorubicin (DOX), a NO donor L-arginine (L-Arg), ultrasmall spinel ferrites (MnFe<sub>2</sub>O<sub>4</sub>), and a poly (lactic-co-glycolic acid) (PLGA) shell. Nanoparticle distribution in the tumor was accurately monitored in real-time through highly enhanced magnetic resonance imaging and photoacoustic imaging. Near-infrared irradiation of tumor cells revealed that MnFe<sub>2</sub>O<sub>4</sub> catalyzes the production of a large amount of reactive oxygen species (ROS) from H<sub>2</sub>O<sub>2</sub>, resulting in a cascade catalysis of L-Arg to trigger NO production in the presence of ROS. In addition, DOX activates niacinamide adenine dinucleotide phosphate oxidase to generate and supply H<sub>2</sub>O<sub>2</sub>. The generated NO improves the vascular endothelial cell integrity and pericellular contractility to promote vessel normalization and induces the activation of endogenous matrix metalloproteinases (mainly MMP-1 and MMP-2) so as to promote extravascular collagen degradation, thereby providing an auxiliary mechanism for efficient nanoparticle delivery and DOX penetration. Moreover, the chemotherapeutic effect of DOX and the photothermal effect of MnFe<sub>2</sub>O<sub>4</sub> served as a chemo-hyperthermia synergistic therapy against TNBC.<h4>Conclusion</h4>The two therapeutic mechanisms, along with an auxiliary mechanism, were perfectly combined to enhance the therapeutic effects. Briefly, multimodality image-guided nanoparticles provide a reliable strategy for the potential application in the fight against TNBC."],"journal":["Journal of nanobiotechnology"],"pubmed_title":["Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy."],"pmcid":["PMC10938667"],"funding_grant_id":["kryc-gg-2117","81701709","2022-15","20200145"],"pubmed_authors":["Du C","Yang L","Wang R","Peng B","Ran H","Luo W","Cheng L","He L","Wang H","Yu X","Liu W"],"additional_accession":[]},"is_claimable":false,"name":"Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.","description":"<h4>Background</h4>Breast cancer ranks first among malignant tumors, of which triple-negative breast cancer (TNBC) is characterized by its highly invasive behavior and the worst prognosis. Timely diagnosis and precise treatment of TNBC are substantially challenging. Abnormal tumor vessels play a crucial role in TNBC progression and treatment. Nitric oxide (NO) regulates angiogenesis and maintains vascular homeostasis, while effective NO delivery can normalize the tumor vasculature. Accordingly, we have proposed here a tumor vascular microenvironment remodeling strategy based on NO-induced vessel normalization and extracellular matrix collagen degradation with multimodality imaging-guided nanoparticles against TNBC called DNMF/PLGA.<h4>Results</h4>Nanoparticles were synthesized using a chemotherapeutic agent doxorubicin (DOX), a NO donor L-arginine (L-Arg), ultrasmall spinel ferrites (MnFe<sub>2</sub>O<sub>4</sub>), and a poly (lactic-co-glycolic acid) (PLGA) shell. Nanoparticle distribution in the tumor was accurately monitored in real-time through highly enhanced magnetic resonance imaging and photoacoustic imaging. Near-infrared irradiation of tumor cells revealed that MnFe<sub>2</sub>O<sub>4</sub> catalyzes the production of a large amount of reactive oxygen species (ROS) from H<sub>2</sub>O<sub>2</sub>, resulting in a cascade catalysis of L-Arg to trigger NO production in the presence of ROS. In addition, DOX activates niacinamide adenine dinucleotide phosphate oxidase to generate and supply H<sub>2</sub>O<sub>2</sub>. The generated NO improves the vascular endothelial cell integrity and pericellular contractility to promote vessel normalization and induces the activation of endogenous matrix metalloproteinases (mainly MMP-1 and MMP-2) so as to promote extravascular collagen degradation, thereby providing an auxiliary mechanism for efficient nanoparticle delivery and DOX penetration. Moreover, the chemotherapeutic effect of DOX and the photothermal effect of MnFe<sub>2</sub>O<sub>4</sub> served as a chemo-hyperthermia synergistic therapy against TNBC.<h4>Conclusion</h4>The two therapeutic mechanisms, along with an auxiliary mechanism, were perfectly combined to enhance the therapeutic effects. Briefly, multimodality image-guided nanoparticles provide a reliable strategy for the potential application in the fight against TNBC.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2026-06-24T03:09:40.488Z","creation":"2026-06-24T03:06:17.872Z"},"accession":"S-EPMC10938667","cross_references":{"pubmed":["38481281"],"doi":["10.1186/s12951-024-02366-y"]}}